Skip to main navigation
Home
Company
Management Team
Board of Directors
MediciNova History
Careers
Current Openings
Clinical
Development
Development Pipeline
Core Programs
MN-001 (NASH)
MN-166 (Neurology Diseases)
MN-221 (Respiratory Diseases)
Non-core Programs
MN-001 (Bronchial Asthma)
MN-001 (Interstitial Cystitis)
MN-029 (Cancer)
MN-221 (Preterm Labor)
Information Request
Business
Development
Partners & Collaborators
Information Request
Investor Relations
Press Releases
Events
Media Archive
Annual Reports
SEC Filings
Stock Quote – TSE
Stock Quote – Nasdaq
Historical Price Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Information Request
Contact
Us
Japanese Site 日本語
Search the site...
Breadcrumb
Home
Investor Relations
IR Contacts
Investor Relations
IR Contacts
IR Contacts
MediciNova, Inc.
David H. Crean, Ph.D.
Chief Business Officer
info@medicinova.com
Investor Toolkit
Print Page
RSS Feeds
Email Alerts
IR Contacts
